Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Resmed Inc (RMD) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 8,866,760
  • Shares Outstanding, K 140,970
  • Annual Sales, $ 1,839 M
  • Annual Income, $ 352 M
  • 36-Month Beta 0.88
  • Price/Sales 4.82
  • Price/Book 5.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.22 +3.97%
on 01/03/17
65.78 -3.24%
on 01/13/17
+1.62 (+2.61%)
since 12/20/16
3-Month
56.59 +12.48%
on 11/09/16
65.78 -3.24%
on 01/13/17
+0.07 (+0.11%)
since 10/20/16
52-Week
53.28 +19.46%
on 01/21/16
70.90 -10.23%
on 08/15/16
+9.89 (+18.40%)
since 01/20/16

Most Recent Stories

More News
ResMed and BMC/3B Medical Settle Global Litigation

- Settlement ends all existing claims between ResMed and BMC/3B Medical

ResMed and BMC/3B Medical Settle Global Litigation

ResMed (NYSE:RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted...

ResMed and BMC/3B Medical Settle Global Litigation

ResMed (NYSE:RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted...

Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD

Medical is one of the broader sectors among the 16 Zacks sectors that is expected to report earnings growth in the fourth quarter.

ResMed (RMD) Q2 Earnings: Disappointment in the Cards?

ResMed Inc. (RMD) is slated to report second-quarter fiscal 2017 results, after market close on Jan 23.

FDA Clears World's Smallest CPAP, ResMed AirMini(TM)

ResMed (NYSE:RMD) announced today at the 35th annual J.P. Morgan Healthcare Conference that the U.S. Food and Drug Administration has cleared ResMed's AirMini, the world's smallest continuous positive...

ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders

ResMed Inc. (RMD) recently formed a joint venture with renowned surgeon and television host Dr. Mehmet Oz and private equity firm Pegasus Capital Advisors, L.P.

Largest Consumer Sleep Study Just Released at CES 2017

--Highlights:

ResMed Achieves Key Milestone in Sleep-Disordered Breathing

After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea....

ResMed Reaches Historic One Billionth Night of Sleep Monitored

- World's largest repository of sleep data - a giant step forward for sleep medicine

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing. Sleep disordered breathing includes sleep apnea and related respiratory conditions. The company sells a comprehensive range of diagnostic and treatment devices...

See More

Support & Resistance

2nd Resistance Point 64.39
1st Resistance Point 64.02
Last Price 63.65
1st Support Level 63.17
2nd Support Level 62.69

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.